DRUG-RESISTANCE MUTATIONS AND TUBERCULOSIS MORTALITY IN HIGH-BURDEN COUNTRIES
Strategies to control Mycobacterium tuberculosis (Mtb) drug resistance include universal access to quality-controlled drug resistance (DR) testing coupled with aligned treatment regimens and patient centred treatment support. We examined the impact of drug resistance mutations (DRM) on mortality in HIV+ and HIV- patients with TB in eight high-burden countries. We included 247 HIV+ and 335…